|
Q2 FY2017
As of Jul 31, 2016
|
Q1 FY2017
As of Apr 30, 2016
|
Q4 FY2016
As of Jan 31, 2016
|
Q3 FY2016
As of Oct 31, 2015
|
Q2 FY2016
As of Jul 31, 2015
|
Q1 FY2016
As of Apr 30, 2015
|
Q4 FY2015
As of Jan 31, 2015
|
Q3 FY2015
As of Oct 31, 2014
|
Q2 FY2015
As of Jul 31, 2014
|
Q1 FY2015
As of Apr 30, 2014
|
Q4 FY2014
As of Jan 31, 2014
|
Q3 FY2014
As of Oct 31, 2013
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Current assets: | ||||||||||||
| Cash and cash equivalents | ||||||||||||
| Restricted cash | ||||||||||||
| Short-term investments | ||||||||||||
| Accounts receivable, net | ||||||||||||
| Inventory | ||||||||||||
| Other current assets | ||||||||||||
| Total current assets | ||||||||||||
| Property and equipment, net | ||||||||||||
| Other assets | ||||||||||||
| Total assets | ||||||||||||
| Liabilities and Stockholders' Deficit | ||||||||||||
| Current liabilities: | ||||||||||||
| Short-term borrowings | ||||||||||||
| Line of credit | ||||||||||||
| Accounts payable | ||||||||||||
| Accrued liabilities | ||||||||||||
| Deferred revenue | ||||||||||||
| Total current liabilities | ||||||||||||
| Convertible senior notes, net | ||||||||||||
| Deferred revenue | ||||||||||||
| Long-term liabilities | ||||||||||||
| Other long-term liabilities | ||||||||||||
| Total liabilities | ||||||||||||
| Stockholders' deficit: | ||||||||||||
| Preferred stock, $0.0001 par value, 10,000 shares authorized as of July 31, 2016; no shares issued and outstanding as of July 31, 2016 and January 31, 2016 | ||||||||||||
| Common stock, $0.0001 par value, 250,000 shares authorized as of July 31, 2016; 25,165 and 24,660 shares issued and outstanding as of July 31, 2016 and January 31, 2016, respectively | ||||||||||||
| Additional paid-in capital | ||||||||||||
| Accumulated other comprehensive income | ||||||||||||
| Accumulated deficit | ||||||||||||
| Total stockholders' deficit | ||||||||||||
| Total liabilities and stockholders' equity |
Loading...